COMMUNIQUÉS West-GlobeNewswire

Otonomy to Report First Quarter 2019 Financial Results and Provide Corporate Update
29/04/2019
Webcast and Conference Call to be Held at 4:30 p.m. EDT on May 6, 2019 SAN DIEGO, April 29, 2019 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative [...]
Silk Road Medical to Report First Quarter 2019 Financial Results on May 8, 2019
29/04/2019
SUNNYVALE, Calif., April 29, 2019 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results [...]
SI-BONE to Present at the Bank of America Merrill Lynch 2019 Health Care Conference
29/04/2019
SANTA CLARA, Calif., April 29, 2019 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that management [...]
Sunesis Pharmaceuticals Announces Refinancing of Existing Loan with $5.5 Million Loan from Silicon Valley Bank
29/04/2019
SOUTH SAN FRANCISCO, Calif., April 29, 2019 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that it has entered into a $5.5 million loan agreement with Silicon Valley Bank . The new [...]
Precision Optics Corporation, Inc. Announces Receipt of $2.2 Million Order For Custom Designed Cardiovascular Endoscope
29/04/2019
GARDNER, Mass., April 29, 2019 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (OTCQB: PEYE) today announced that it has received a follow-on order totaling $2,216,000 from CardioFocus, Inc. for the manufacture [...]
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2019 Financial Results
29/04/2019
-Enrollment ongoing in Phase 1/2 clinical trials of CTX001™ for patients with severe hemoglobinopathies- -IND and CTA approved for CTX110™, wholly-owned allogeneic CAR-T cell therapy targeting CD19+ malignancies- -On [...]
G1 Therapeutics Announces Positive Feedback from Trilaciclib End-of-Phase 2 Meeting with FDA; Expects to File NDA in 2020
29/04/2019
Research Triangle Park, N.C., April 29, 2019 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today provided a regulatory update on trilaciclib, a first-in-class [...]
Mustang Bio Announces Proposed Public Offering of Common Stock
29/04/2019
NEW YORK, April 29, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into [...]
SunGen Pharma Receives its Fourth and Fifth ANDA Approvals from US FDA
29/04/2019
PRINCETON, N.J., April 29, 2019 (GLOBE NEWSWIRE) -- SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products, today announced it [...]
IRIDEX’s MicroPulse® Laser Technology Featured in Several Glaucoma and Retina Research Presentations at Major Ophthalmic Industry Conferences
29/04/2019
MOUNTAIN VIEW, Calif., April 29, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced [...]
Innovate Biopharmaceuticals Announces $8.7 Million Registered Direct Offering Priced At-the-Market
29/04/2019
RALEIGH, N.C., April 29, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (NASDAQ: INNT) today announced that it has entered into securities purchase agreements with certain institutional investors providing [...]
Emendo Biotherapeutics Enters Into Licensing Option Agreement With Takeda for its OMNI Nuclease Program
29/04/2019
NEW YORK, April 29, 2019 (GLOBE NEWSWIRE) -- Emendo Biotherapeutics Inc. today announced that the company signed a licensing option agreement with Takeda Pharmaceutical Company Limited. As part of the transaction, [...]
Trading by management and close relations of management
29/04/2019
Please read the full announcement in PDF Attachment 2019_10_Trading_by_management_EN
Agreement between Novozymes and Novo Holdings A/S on trading of shares as part of Novozymes share buyback program
29/04/2019
Please read the full announcement in PDF Attachment 2019_09_Novo_Holding_stock_buyback_program_EN
Ronald McDonald House Charities Announces Winners of the 2019 Remarkable Impact Grants
29/04/2019
Through tremendous support from AbbVie, winning Chapters will receive funding to support enhanced family-centered services, deepening the impact on families and connections within the community CHICAGO, April 29, 2019 ( [...]
Lawsuit against NYC Vaccine Order Dismissed, States Association of American Physicians and Surgeons (AAPS)
29/04/2019
TUCSON, Ariz., April 29, 2019 (GLOBE NEWSWIRE) -- Brooklyn Judge Lawrence Knipel has dismissed a lawsuit ( C.F. v. NYC Health Commissioner ) brought by five mothers against Mayor Bill de Blasio’s emergency order [...]
Ossur Hf : Transactions in relation to share buyback program
29/04/2019
Announcement no. 27/2019 29 April 2019 Transactions in relation to share buyback program On 9 October 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2018. The purpose of the share [...]
Spineway : 2018 annual results
29/04/2019
2018 annual results Implementation of the NEWWAY 2021 plan Strategic acquisition in Latin America In thousands of euros Consolidated accounts 2018 2017 Revenue 6 515 9 138 Gross margin % of revenue 4 201 64.5% 6 151 67. [...]
SPINEWAY : Résultats annuels 2018
29/04/2019
Résultats annuels 2018 Déploiement du plan NEWWAY 2021 Acquisition stratégique en Amérique Latine En Milliers d'euros Comptes consolidés 2018 2017 Chiffre d'affaires 6 515 9 138 Marge Brute % CA 4 201 64,5% 6 151 67,3% [...]

Pages